us physical - USPH

USPH

Close Chg Chg %
84.02 0.21 0.24%

Closed Market

84.23

+0.21 (0.24%)

Volume: 183.85K

Last Updated:

Jan 12, 2026, 3:59 PM EDT

Company Overview: us physical - USPH

USPH Key Data

Open

$82.70

Day Range

81.47 - 84.41

52 Week Range

62.77 - 93.56

Market Cap

$1.28B

Shares Outstanding

15.20M

Public Float

14.90M

Beta

1.28

Rev. Per Employee

N/A

P/E Ratio

35.32

EPS

$2.38

Yield

214.39%

Dividend

$0.45

EX-DIVIDEND DATE

Nov 17, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

180.03K

 

USPH Performance

1 Week
 
6.44%
 
1 Month
 
4.18%
 
3 Months
 
-4.29%
 
1 Year
 
-3.49%
 
5 Years
 
-34.31%
 

USPH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About us physical - USPH

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The company was founded in 1990 and is headquartered in Houston, TX.

USPH At a Glance

U.S. Physical Therapy, Inc.
1300 West Sam Houston Parkway South
Houston, Texas 77042-2447
Phone 1-713-297-7000 Revenue 671.35M
Industry Medical/Nursing Services Net Income 27.73M
Sector Health Services 2024 Sales Growth 11.002%
Fiscal Year-end 12 / 2025 Employees 7,028
View SEC Filings

USPH Valuation

P/E Current 34.182
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 48.194
Price to Sales Ratio 1.991
Price to Book Ratio 2.739
Price to Cash Flow Ratio 17.58
Enterprise Value to EBITDA 22.065
Enterprise Value to Sales 2.771
Total Debt to Enterprise Value 0.159

USPH Efficiency

Revenue/Employee 95,524.331
Income Per Employee 3,945.361
Receivables Turnover 7.755
Total Asset Turnover 0.601

USPH Liquidity

Current Ratio 1.183
Quick Ratio 1.183
Cash Ratio 0.356

USPH Profitability

Gross Margin 19.365
Operating Margin 9.776
Pretax Margin 8.968
Net Margin 4.13
Return on Assets 2.481
Return on Equity 5.746
Return on Total Capital 3.536
Return on Invested Capital 3.891

USPH Capital Structure

Total Debt to Total Equity 60.383
Total Debt to Total Capital 37.649
Total Debt to Total Assets 24.464
Long-Term Debt to Equity 49.986
Long-Term Debt to Total Capital 31.167
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Us Physical - USPH

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
495.02M 553.14M 604.80M 671.35M
Sales Growth
+17.04% +11.74% +9.34% +11.00%
Cost of Goods Sold (COGS) incl D&A
384.10M 450.31M 492.82M 541.34M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
11.59M 14.74M 15.70M 18.68M
Depreciation
7.89M 8.22M 8.42M 9.13M
Amortization of Intangibles
3.70M 6.52M 7.27M 9.55M
COGS Growth
+16.22% +17.24% +9.44% +9.85%
Gross Income
110.93M 102.83M 111.99M 130.00M
Gross Income Growth
+19.96% -7.30% +8.91% +16.09%
Gross Profit Margin
+22.41% +18.59% +18.52% +19.36%
2021 2022 2023 2024 5-year trend
SG&A Expense
40.25M 36.92M 42.43M 64.37M
Research & Development
- - - -
-
Other SG&A
40.25M 36.92M 42.43M 64.37M
SGA Growth
+11.40% -8.28% +14.94% +51.72%
Other Operating Expense
- - - -
-
Unusual Expense
2.67M 6.60M 16.46M 2.72M
EBIT after Unusual Expense
68.01M 59.32M 53.09M 62.91M
Non Operating Income/Expense
6.12M 2.03M 5.59M 5.31M
Non-Operating Interest Income
- - 3.77M 3.94M
-
Equity in Earnings of Affiliates
112.00K 1.18M 955.00K 1.01M
Interest Expense
942.00K 5.78M 9.30M 8.02M
Interest Expense Growth
-42.35% +513.48% +60.98% -13.84%
Gross Interest Expense
942.00K 5.78M 9.30M 8.02M
Interest Capitalized
- - - -
-
Pretax Income
73.20M 55.57M 49.38M 60.21M
Pretax Income Growth
+11.73% -24.08% -11.15% +21.94%
Pretax Margin
+14.79% +10.05% +8.16% +8.97%
Income Tax
15.27M 12.16M 12.16M 14.61M
Income Tax - Current - Domestic
9.58M (252.00K) 7.51M 9.73M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
5.69M 12.42M 4.65M 4.87M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
112.00K 1.18M 955.00K 1.01M
Other After Tax Income (Expense)
3.32M 994.00K 3.47M 1.27M
Consolidated Net Income
61.25M 44.40M 40.69M 46.87M
Minority Interest Expense
30.10M 15.14M 22.55M 19.14M
Net Income
31.14M 29.26M 18.14M 27.73M
Net Income Growth
-2.00% -6.04% -38.01% +52.86%
Net Margin Growth
+6.29% +5.29% +3.00% +4.13%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
31.14M 29.26M 18.14M 27.73M
Preferred Dividends
- - - -
-
Net Income Available to Common
31.14M 29.26M 18.14M 27.73M
EPS (Basic)
2.4146 2.2535 1.2786 1.8407
EPS (Basic) Growth
-2.48% -6.67% -43.26% +43.96%
Basic Shares Outstanding
12.90M 12.98M 14.19M 15.06M
EPS (Diluted)
2.4146 2.2535 1.2786 1.8407
EPS (Diluted) Growth
-2.48% -6.67% -43.26% +43.96%
Diluted Shares Outstanding
12.90M 12.98M 14.19M 15.06M
EBITDA
82.27M 80.66M 85.25M 84.31M
EBITDA Growth
+23.02% -1.96% +5.70% -1.10%
EBITDA Margin
+16.62% +14.58% +14.10% +12.56%

Snapshot

Average Recommendation BUY Average Target Price 106.833
Number of Ratings 7 Current Quarters Estimate 0.598
FY Report Date 03 / 2026 Current Year's Estimate 2.987
Last Quarter’s Earnings 0.672 Median PE on CY Estimate N/A
Year Ago Earnings 2.628 Next Fiscal Year Estimate 3.228
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 6 3
Mean Estimate 0.60 0.87 2.99 3.23
High Estimates 0.73 0.93 3.11 3.39
Low Estimate 0.49 0.82 2.77 3.06
Coefficient of Variance 20.35 6.29 3.82 5.08

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 6 6
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Us Physical - USPH

Date Name Shares Transaction Value
Nov 26, 2025 Graham D. Reeve COO 20,740 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $71.01 per share 1,472,747.40
Mar 21, 2025 Carey P. Hendrickson Chief Financial Officer 28,506 Bona fide gift 0.00
Feb 27, 2025 Christopher J. Reading Chairman of the Board and CEO; Director 116,088 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Richard Steven Binstein EVP Gen l Counsel & Secretary 19,867 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Eric Joseph Williams President and COO 26,964 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Us Physical in the News